The global neurostimulator market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The deep brain stimulator segment is expected to account for the largest share of the market in terms of revenue, followed by spinal cord stimulator and vagus nerve stimulator segments. The deep brain stimulator segment is projected to grow at a CAGR of 6.2% during the forecast period, owing to its wide range of applications in various neurological disorders such as Parkinson's disease and epilepsy.
North America accounted for the largest share in terms of revenue in 2018 due to high adoption rates among patients with neurological disorders such as Parkinson's disease and epilepsy. Europe was second-largest contributor due to high adoption rates among patients with urinary incontinence and fecal incontinence, which are prevalent across European countries such as Germany, France, Italy, Spain etc, owing to aging population demographics coupled with increasing awareness about these conditions among people living there. Asia Pacific is projected be fastest-growing region over next five years due its large population base coupled with increasing awareness about these conditions among people living there.
-The Neurostimulator market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The Neurostimulator market is driven by the increasing prevalence of neurological disorders, such as Parkinson's disease and epilepsy, which are expected to drive the demand for neurostimulators.
-Increasing awareness about the benefits of neurostimulators among patients and physicians will also drive the growth of this market.
Industry Growth Insights published a new data on “Neurostimulator Market”. The research report is titled “Neurostimulator Market research by Types (Deep Brain Stimulator, Spinal cord stimulator, Vagus nerve stimulator, Other), By Applications (Parkinson, Urinary incontinence and fecal incontinence, Epilepsy, Other), By Players/Companies Medtronic, Abbott Laboratories, Boston Scientific, LivaNova PLC, Cochlear Limited, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurostimulator Market Research Report
By Type
Deep Brain Stimulator, Spinal cord stimulator, Vagus nerve stimulator, Other
By Application
Parkinson, Urinary incontinence and fecal incontinence, Epilepsy, Other
By Companies
Medtronic, Abbott Laboratories, Boston Scientific, LivaNova PLC, Cochlear Limited, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Neurostimulator Market Report Segments:
The global Neurostimulator market is segmented on the basis of:
Types
Deep Brain Stimulator, Spinal cord stimulator, Vagus nerve stimulator, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson, Urinary incontinence and fecal incontinence, Epilepsy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott Laboratories
- Boston Scientific
- LivaNova PLC
- Cochlear Limited
- Sonova Holding AG
- William Demant Holding A/S
- Nurotron Biotechnology Co
Highlights of The Neurostimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Deep Brain Stimulator
- Spinal cord stimulator
- Vagus nerve stimulator
- Other
- By Application:
- Parkinson
- Urinary incontinence and fecal incontinence
- Epilepsy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurostimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neurostimulator is a medical device that stimulates the nervous system. Neurostimulators are used to treat conditions such as epilepsy, depression, and chronic pain.
Some of the key players operating in the neurostimulator market are Medtronic, Abbott Laboratories, Boston Scientific, LivaNova PLC, Cochlear Limited, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co.
The neurostimulator market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurostimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurostimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurostimulator Market - Supply Chain
4.5. Global Neurostimulator Market Forecast
4.5.1. Neurostimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurostimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurostimulator Market Absolute $ Opportunity
5. Global Neurostimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurostimulator Market Size and Volume Forecast by Type
5.3.1. Deep Brain Stimulator
5.3.2. Spinal cord stimulator
5.3.3. Vagus nerve stimulator
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurostimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurostimulator Market Size and Volume Forecast by Application
6.3.1. Parkinson
6.3.2. Urinary incontinence and fecal incontinence
6.3.3. Epilepsy
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurostimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurostimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurostimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurostimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurostimulator Demand Share Forecast, 2019-2026
9. North America Neurostimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurostimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurostimulator Market Size and Volume Forecast by Application
9.4.1. Parkinson
9.4.2. Urinary incontinence and fecal incontinence
9.4.3. Epilepsy
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurostimulator Market Size and Volume Forecast by Type
9.7.1. Deep Brain Stimulator
9.7.2. Spinal cord stimulator
9.7.3. Vagus nerve stimulator
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurostimulator Demand Share Forecast, 2019-2026
10. Latin America Neurostimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurostimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurostimulator Market Size and Volume Forecast by Application
10.4.1. Parkinson
10.4.2. Urinary incontinence and fecal incontinence
10.4.3. Epilepsy
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurostimulator Market Size and Volume Forecast by Type
10.7.1. Deep Brain Stimulator
10.7.2. Spinal cord stimulator
10.7.3. Vagus nerve stimulator
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurostimulator Demand Share Forecast, 2019-2026
11. Europe Neurostimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurostimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurostimulator Market Size and Volume Forecast by Application
11.4.1. Parkinson
11.4.2. Urinary incontinence and fecal incontinence
11.4.3. Epilepsy
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurostimulator Market Size and Volume Forecast by Type
11.7.1. Deep Brain Stimulator
11.7.2. Spinal cord stimulator
11.7.3. Vagus nerve stimulator
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Typ
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurostimulator Demand Share, 2019-2026
12. Asia Pacific Neurostimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurostimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurostimulator Market Size and Volume Forecast by Application
12.4.1. Parkinson
12.4.2. Urinary incontinence and fecal incontinence
12.4.3. Epilepsy
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurostimulator Market Size and Volume Forecast by Type
12.7.1. Deep Brain Stimulator
12.7.2. Spinal cord stimulator
12.7.3. Vagus nerve stimulator
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurostimulator Demand Share, 2019-2026
13. Middle East & Africa Neurostimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurostimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurostimulator Market Size and Volume Forecast by Application
13.4.1. Parkinson
13.4.2. Urinary incontinence and fecal incontinence
13.4.3. Epilepsy
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurostimulator Market Size and Volume Forecast by Type
13.7.1. Deep Brain Stimulator
13.7.2. Spinal cord stimulator
13.7.3. Vagus nerve stimulator
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurostimulator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurostimulator Market: Market Share Analysis
14.2. Neurostimulator Distributors and Customers
14.3. Neurostimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LivaNova PLC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cochlear Limited
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sonova Holding AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. William Demant Holding A/S
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nurotron Biotechnology Co
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
